Gholson LyonCold Spring Harbour Laboratory Stopping 23andMe Will Only Delay the Revolution Medicine Needs (Op-Ed) Opinion Genetic testing is a powerful tool yet, the US Food and Drug Administration (FDA) has ordered 23andMe to stop marketing their service. Opinion
